Beyond AT(N): Integrating Neuroimaging, Fluid Biomarkers, and Artificial Intelligence for Alzheimer’s Disease Diagnosis—A Review
This review consists of three parts related to the AT(N) framework, providing a comprehensive overview of biomarker-based diagnosis of Alzheimer’s disease (AD). In recent years, management of AD has shifted from a symptom-based approach toward biological biomarkers targeted at the amyloid (A), tau (T), and neurodegener...